Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
13/5 23:06
Key PointsAvidity Partners added 259,700 shares of Enliven Therapeutics in the first quarter; the estimated transaction value was $7.19 million (based on quarterly average pricing)....